EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Centromere protein U mediates the ubiquitination and degradation of RPS3 to facilitate temozolomide resistance in glioblastoma

Jinmin Sun, Wenyu Zhao, Lei Zhang, Sicheng Wu, Senrui Xue, Haowei Cao, Biao Xu, Xinmiao Li, Nan Hu, Tao Jiang, Yixin Xu, Zhifei Wang und 2 weitere

Drug Resistance Updates · 2025-05 · 80 · 101214

DOI: 10.1016/j.drup.2025.101214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2025-05. Verfasst von Jinmin Sun und 13 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou 221…. Hauptthemen laut MEDLINE: Temozolomide, Drug Resistance, Neoplasm, Glioblastoma, Antineoplastic Agents, Alkylating. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideDrug Resistance, NeoplasmGlioblastomaAntineoplastic Agents, AlkylatingBrain NeoplasmsRibosomal ProteinsHumansAnimalsUbiquitinationMiceCell Line, TumorXenograft Model Antitumor AssaysDNA RepairOrganoidsGene Expression Regulation, NeoplasticProteolysis

Stichwörter der Autor:innen

CENPUDNA damage repairGlioblastomaRAD51RPS3TMZ resistance

Substanzen

TemozolomideAntineoplastic Agents, AlkylatingRibosomal Proteins

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou 221004, China; Laboratory of Clinical and Experimental Pathology, Departm…
  • Laboratory of Clinical and Experimental Pathology, Department of Pathology, Xuzhou Medical University, Xuzhou 221004, China.
  • Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221004, China.
  • Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou 221004, China.
  • Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221004, China.
  • Department of Neurosurgery, The Third Xiangya Hospital, Central South University, Changsha 410013, China. Electronic address: doctorwangzhifei@163.com.

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Sun, J., Zhao, W., Zhang, L., Wu, S., Xue, S., Cao, H., Xu, B., Li, X., Hu, N., Jiang, T., Xu, Y., Wang, Z., Zhang, C., & Ren, J. (2025). Centromere protein U mediates the ubiquitination and degradation of RPS3 to facilitate temozolomide resistance in glioblastoma. Drug Resistance Updates, 80, 101214. https://doi.org/10.1016/j.drup.2025.101214

Vancouver

Sun J, Zhao W, Zhang L, Wu S, Xue S, Cao H, et al. Centromere protein U mediates the ubiquitination and degradation of RPS3 to facilitate temozolomide resistance in glioblastoma. Drug Resistance Updates. 2025;80:101214. doi:10.1016/j.drup.2025.101214

BibTeX
@article{Sun2025,
  author = {Sun, Jinmin and Zhao, Wenyu and Zhang, Lei and Wu, Sicheng and Xue, Senrui and Cao, Haowei and Xu, Biao and Li, Xinmiao and Hu, Nan and Jiang, Tao and Xu, Yixin and Wang, Zhifei and Zhang, Chao and Ren, Jing},
  title = {Centromere protein U mediates the ubiquitination and degradation of RPS3 to facilitate temozolomide resistance in glioblastoma},
  journal = {Drug Resistance Updates},
  year = {2025},
  volume = {80},
  pages = {101214},
  doi = {10.1016/j.drup.2025.101214}
}
Kostenlos starten →